Modeling Kaempferol as a Potential Pharmacological Agent for COVID-19/PF Co-Occurrence Based on Bioinformatics and System Pharmacological Tools

• Váldodahkkit: Yong Jiang (Dahkki), Yi-Zi Xie (Dahkki), Chen-Wen Peng (Dahkki), Kai-Nan Yao (Dahkki), Xue-Ying Lin (Dahkki), Shao-Feng Zhan (Dahkki), Hong-Fa Zhuang (Dahkki), Hui-Ting Huang (Dahkki), Xiao-Hong Liu (Dahkki), Xiu-Fang Huang (Dahkki), Hang Li (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Objective: People suffering from coronavirus disease 2019 (COVID-19) are prone to develop pulmonary fibrosis (PF), but there is currently no definitive treatment for COVID-19/PF co-occurrence. Kaempferol with promising antiviral and anti-fibrotic effects is expected to become a potential treatment f...